Microglial activation in early stages of amyloid β protein deposition
The DOI matches its Crossref record; 33 of the 33 references it cites were found in a registry or an index.
Abstract
The present study was undertaken to investigate the relationship of microglial activation to amyloid beta protein (A beta) deposition, particularly at the early stage. Using single and double immunostaining methods with a panel of microglia markers and antibodies against A beta and amyloid beta protein precursor (APP), we examined the cerebrum and cerebella of both Alzheimer's disease (AD) and non-demented subjects obtained at autopsy. In nondemented, middle-aged subjects that had small amounts of cerebral A beta deposits, approximately 70% of the diffuse plaques contained ramified microglia. However, no evidence of microglial activation was found in diffuse plaques in any of the non-demented subjects. Dual immunostaining of sections of cerebral cortex using antibodies against A beta and major histocompatibility complex class II antigen showed that in AD subjects, approximately 20% of total diffuse plaques contained a few, activated microglia. Most of these plaques were defined as a transitional from between diffuse and primitive plaques. Both primitive and classic plaques in the cerebral cortex of AD subjects consistently contained clusters of activated microglia. Subpial A beta deposits without neuritic changes lacked microglial activation. In the cerebellum, all of the diffuse plaques lacked microglial activation, and activated microglia in the compact plaques were not as hypertrophic as those in cerebral primitive/classic plaques. Our findings indicate that microglial reactions are absent in the early stages of A beta deposition, and it occurs during the transition from diffuse to primitive plaques, when amounts of A beta deposits and the degree of neuritic changes increase.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In humans, early, non-fibrillar diffuse plaques are associated with little or no microglial clustering (53) and accumulate little or no complement proteins (8, 9).”
From Complement C3 deficiency protects against neurodegeneration in aged plaque-rich APP/PS1 mice (2017) · cites this paper as [53]
Citations
Cites
The precursor of Alzheimer's disease amyloid A4 protein resembles a cell-surface receptor
Kang, J., Lemaire, H.-G., Unterbeck, A., Salbaum, J. M., Masters, C. L., Grzeschik, K.-H., Multhaup, G., Beyreuther, K., & Müller-Hill, B. (1987) · Nature · doi:10.1038/325733a0 · Cited by 4,619 · cited 1×
“A β is derived from a larger membrane-bound protein, amyloid β protein precursor (APP) [ 11 ].”
BackgroundDiagnosis of Alzheimer's Disease
Khachaturian, Z. S. (1985) · Archives of Neurology · doi:10.1001/archneur.1985.04060100083029 · Cited by 2,499
Microglia: Intrinsic immuneffector cell of the brain
Gehrmann, J., Matsumoto, Y., & Kreutzberg, G. W. (1995) · Brain Research Reviews · doi:10.1016/0165-0173(94)00015-h · Cited by 1,119 · cited 1×
“Microglial activation takes place in a graded fashion: first, activated microglia become hypertrophic with increased expression of several marker molecules (such as MHC antigens); second, phagocytic microglia continue to swell and express additional marker molecules characteristic of peripheral macrophages [ 7 ].”
BackgroundRelationship of microglia and astrocytes to amyloid deposits of Alzheimer disease
Itagaki, S., McGeer, P. L., Akiyama, H., Zhu, S., & Selkoe, D. (1989) · Journal of Neuroimmunology · doi:10.1016/0165-5728(89)90115-x · Cited by 940 · cited 1×
“In a large number of immunohistochemical studies, activated microglia have been found to be clustered in congophilic plaques, but not in diffuse plaques [1, 3, 10 , 13, 20, 30].”
BackgroundAmyloid A4 Protein and Its Precursor in Down's Syndrome and Alzheimer's Disease
Rumble, B., Retallack, R., Hilbich, C., Simms, G., Multhaup, G., Martins, R., Hockey, A., Montgomery, P., Beyreuther, K., & Masters, C. L. (1989) · New England Journal of Medicine · doi:10.1056/nejm198906013202203 · Cited by 653 · cited 1×
“syndrome patients as well as in middle-aged, non-demented individuals may represent the earliest stage of A β deposition [ 25 , 29].”
BackgroundT. Griffin, W. S., Sheng, J. G., Roberts, G. W., & Mrak, R. E. (1995) · Journal of Neuropathology and Experimental Neurology · doi:10.1097/00005072-199503000-00014 · Cited by 549
Yamaguchi, H., Hirai, S., Morimatsu, M., Shoji, M., & Ihara, Y. (1988) · Acta Neuropathologica · doi:10.1007/bf00689591 · Cited by 283
Self-citationFrackowiak, J., Wisniewski, H. M., Wegiel, J., Merz, G. S., Iqbal, K., & Wang, K. C. (1992) · Acta Neuropathologica · doi:10.1007/bf00227813 · Cited by 276
MHC class II‐positive microglia in human brain: Association with alzheimer lesions
Perlmutter, L. S., Scott, S. A., Barrón, E., & Chui, H. C. (1992) · Journal of Neuroscience Research · doi:10.1002/jnr.490330407 · Cited by 232 · cited 1×
“Certain characteristics of the microglial markers have already been reported: (1) LN1 reacts mostly with resting microglia [27]; (2) Ki-M1p in resting and reactive microglia is expressed most consistently in formalin-fixed, paraffin-embedded tissues [21, 28]; and (3) LN3 and CR3.43 can be used as markers for activated…”
BackgroundWisniewski, H. M., Wegiel, J., Wang, K. C., & Lach, B. (1992) · Acta Neuropathologica · doi:10.1007/bf00311383 · Cited by 221
Cited by
Items 101–133 of 133
Diversity of glial cell components in pilocytic astrocytoma
Tanaka, Y., Sasaki, A., Ishiuchi, S., & Nakazato, Y. (2008) · Neuropathology · doi:10.1111/j.1440-1789.2008.00896.x · Cited by 18
Self-citationRole of calmodulin in the differentiation/activation of microglial cells
Casal, C., Tusell, J. M., & Serratosa, J. (2001) · Brain Research · doi:10.1016/s0006-8993(01)02380-0 · Cited by 16
Rommy von Bernhardi, M., Ramírez, G., Matile, H., & Döbeli, H. (2001) · European Journal of Neuroscience · doi:10.1046/j.0953-816x.2001.01715.x · Cited by 16
“Another hallmark of AD is gliosis in the proximity of senile plaques (Giulian et al., 1995a; Sheng et al., 1995), although there is controversy regarding their presence in diffuse plaques (Sasaki et al., 1997).”
BackgroundYassaghi, Y., Nazerian, Y., Ghasemi, M., Nazerian, A., Sayehmiri, F., Perry, G. L., & Pourbadie, H. G. (2024) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.18554 · Cited by 15
Measurement of intracellular calcium levels by the fluorescent Ca2+ indicator Calcium-Green
Silei, V., Fabrizi, C., Venturini, G., Tagliavini, F., Salmona, M., Bugiani, O., & Lauro, G. M. (2000) · Brain Research Protocols · doi:10.1016/s1385-299x(00)00003-9 · Cited by 15
Lee, J., Mizuno, K., Watanabe, H., Lee, I., Tsumita, T., Hida, K., Yawaka, Y., Kitagawa, Y., Hasebe, A., Iimura, T., et al. (2024) · Journal of Neuroinflammation · doi:10.1186/s12974-024-03192-7 · Cited by 17
Biological Markers for Alzheimer's Disease
Tapiola, T. (2001) · Cited by 28
Proteomics in Traditional Chinese Medicine with an Emphasis on Alzheimer’s Disease
Sulistio, Y. A., & Heese, K. (2015) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2015/393510 · Cited by 11
Mechanisms of Microglial Activation by Amyloid Precursor Protein and its Proteolytic Fragments
Austin, S. A., & Combs, C. K. (2007) · Springer eBooks · doi:10.1007/978-0-387-73894-9_2 · Cited by 11
“the diffuse plaques (Itagaki et al., 1989; Mattiace et al., 1990; Sasaki et al., 1997).”
BackgroundPrP106-126 and Aβ1-42 Peptides Induce BV-2 Microglia Chemotaxis and Proliferation
Tu, J., Yang, L., Zhou, X., Qi, K., Wang, J., Kouadir, M., Xu, L., Yin, X., & Zhao, D. (2013) · Journal of Molecular Neuroscience · doi:10.1007/s12031-013-0140-3 · Cited by 9
Liew, Y., Huang, C.-T., Chou, S. P., Kuo, Y., Chou, S.-H., Leu, J.-Y., Tzeng, W.-F., Wang, S., Tang, M.-C., & Huang, R.-F. S. (2010) · Molecules · doi:10.3390/molecules15031632 · Cited by 8
“These findings are in agreement with results of numerous human and animal studies, which showed that synthetic Aβ peptide activation of microglia induces secretion of cytotoxic agents such as reactive oxygen intermediates [4–6,27].”
The Role of the Immune System in Alzheimer's Disease
Cohen, R. M. (2009) · FOCUS The Journal of Lifelong Learning in Psychiatry · doi:10.1176/foc.7.1.foc28 · Cited by 10
Alzghool, O. M., Aarnio, R., Helin, J. S., Wahlroos, S., Keller, T., Matilainen, M., Solis, J., Danon, J. J., Kassiou, M., Snellman, A., et al. (2024) · EJNMMI Research · doi:10.1186/s13550-024-01085-7 · Cited by 5
Malyshev, I. Y. (2013) · SpringerBriefs in biochemistry and molecular biology · doi:10.1007/978-94-007-5943-5_8 · Cited by 4
Neuroprotection Versus Neurotoxicity
Biber, K. P. H., & Block, M. L. (2014) · Springer eBooks · doi:10.1007/978-1-4939-1429-6_6 · Cited by 3
Pathological glial reactions in neurodegenerative disorders: prospects for future therapeutics
Schubert, P., & Ferroni, S. (2003) · Expert Review of Neurotherapeutics · doi:10.1586/14737175.3.3.279 · Cited by 3
Jager, R. M. D., Lee, A., Sigalov, A., & Taga, M. F. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.02.01.577128 · Cited by 3
How does type 2 diabetes modify the risk of Alzheimer's disease?
Sutherland, G. T., Chen, A., Nguyen‐Hao, H., Mundell, H. D., Aladyeva, E., Hofer, M. J., Harari, O., & Twigg, S. M. (2026) · Alzheimer s & Dementia · doi:10.1002/alz.71471 · Cited by 4
“27 Disease-promoting microglia have been shown to promote neuritic A β plaque load 186 and link A β accumulation with tau hyperphosphorylation, 187 tau seeding, and spreading.”
Dual Role of Microglial TREM2 in Neuronal Degeneration and Regeneration after Axotomy
Pottorf, T. S., Lane, E. L., Haley-Johnson, Z., Ukmar, D. N., Amores-Sanchez, V., Correa-Torres, P. M., & Álvarez, F. J. (2026) · Journal of Neuroscience · doi:10.1523/jneurosci.0112-26.2026 · Cited by 2
Prospects of Non-drug Approaches to Alzheimer's Disease
Manukhina, E. B., Wiegant, F. A. C., Torshin, V. I., Goryacheva, A. V., Khomenko, I. P., Круглов, С. В., Mashina, S. Y., Pokidyshev, D. A., Popkova, E. A., Pshennikova, M. G., et al. (2004) · Biology Bulletin · doi:10.1023/b:bibu.0000036943.66185.50 · Cited by 6
Decline of Immune Responsiveness: A Pathogenetic Factor in Alzheimer’s Disease?
Richartz-Salzburger, E., & Koehler, N. K. U. (2009) · Springer eBooks · doi:10.1007/978-1-4020-9063-9_61 · Cited by 4
“Histopathological studies on AD microglia showd altered morphology indicating a functional impairment (De Witt et al. 1998; Sasaki et al. 1997).”
BackgroundMujtaba, S., Patro, N., & Patro, I. K. (2025) · Annals of Neurosciences · doi:10.1177/09727531251324716 · Cited by 1
“58 Inflammation is the major link between ELS and neuro - logical disorders and is mediated by microglia by secreting pro-inflammatory cytokines and chemokines, and acts as the major miscreant in most neurodegenerative diseases.”
Astrocytes and microgliain Alzheimer's disease
Barger, S. W. (2003) · Advances in molecular and cell biology · doi:10.1016/s1569-2558(03)31039-2 · Cited by 2
Patterson, P. H. (2000) · Research and perspectives in neurosciences · doi:10.1007/978-3-642-59643-8_12 · Cited by 1
Neuroinflammation in Alzheimer’s Disease: Potential Targets for Disease-Modifying Drugs
Hüll, M., & Hampel, H. J. (2002) · Springer eBooks · doi:10.1007/978-3-662-05073-6_9 · Cited by 1
The structural core of prion disease
Boshuizen, R. S. (2010) · Utrecht University Repository (Utrecht University)
Manipulating Phagocyte Activity in Alzheimer's Disease
Combs, C. K. (2010) · Journal of Alzheimer s Disease · doi:10.3233/jad-2010-090896
“These cells are often, but not always, reported in association with deposits of fibrillar amyloid-β (Aβ) peptide [4–7], and this proximity has helped support the idea that the microglia are responding to Aβ by acquiring a reactive phenotype.”
The role of immune activation in Alzheimer's disease
Smits, H. A. (2001) · Utrecht University Repository (Utrecht University)
Open peer commentary Inflammation and Alzheimer's disease
Akiyama, H., Barger, S. W., Barnum, S. R., Bradt, B. M., Bauer, J., Cole, G. M., Cooper, N. R., Eikelenboom, P., Emmerling, M. R., Fiebich, B. L., et al. (2000)
Role of Microglia and Astrocytesin Alzheimer’s Disease
Schubert, P., & Ferroni, S. (2004) · CRC Press eBooks · doi:10.1201/9781420039740.ch18
Alzghool, O. M., Aarnio, R., Helin, J. S., Wahlroos, S., Keller, T., Matilainen, M., Solis, J., Danon, J. J., Kassiou, M., Snellman, A., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26689604
Gouilly, D. (2022) · theses.fr (ABES) · doi:10.70675/a0fe7c9bzf66ez4bdbzbc10zb5444b49c42e · Cited by 1
Moonen, S., Ospitalieri, S., Vandenberghe, R. R., Thal, D. R., & Strooper, B. (2026) · Research Square · doi:10.21203/rs.3.rs-11446407/v1
Metadata
- Authors
- Sasaki, A., Yamaguchi, H., Ogawa, A., Sugihara, S., & Nakazato, Y.
- Affiliations
- Gunma University (JP)
- Gunma Prefectural Cancer Center (JP)
- ORCID
- Sasaki, A.
- Venue
- Acta Neuropathologica
- Published
- 1997-10-12
- Volume
- 94
- Issue
- 4
- Pages
- 316-322
- ISSN
- 0001-6322 (ISSN-L)
- 1432-0533
- OpenAlex
- W1994360125
- Cited by
- 132
- References
- 33
- Citations by year
- 2026: 2 · 2025: 1 · 2024: 7 · 2023: 2 · 2022: 3 · 2021: 2 · 2020: 2 · 2019: 1 · 2018: 2 · 2017: 5 · 2016: 4 · 2015: 5 · 2014: 3 · 2013: 4 · 2012: 3
- FWCI
- 3.02
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Acta Neuropathologica (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Keywords
- microglial activation, Alzheimer's disease, diffuse plaques, MHC class II, amyloid precursor protein, cerebellum, cerebral cortex
- MeSH terms
- Aged, Alzheimer Disease, Cerebellum, Cerebral Cortex, Humans, Immunohistochemistry, Middle Aged, Amyloid beta-Peptides, Microglia, Plaque, Amyloid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.